Latest Insider Transactions at Healthcare Realty Trust Inc (HR)
This section provides a real-time view of insider transactions for Healthcare Realty Trust Inc (HR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HEALTHCARE REALTY TRUST INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HEALTHCARE REALTY TRUST INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 20
2022
|
Christann M Vasquez Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
28,535
-100.0%
|
-
|
Jul 20
2022
|
John Knox Singleton Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
19,082
-100.0%
|
-
|
Jul 20
2022
|
John Knox Singleton Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
38,197
-100.0%
|
-
|
Jul 20
2022
|
Julie F. Wilson EVP - Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
93,085
-100.0%
|
-
|
Jul 20
2022
|
James Joseph Iv Kilroy Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,921
-100.0%
|
-
|
Jul 20
2022
|
Todd J Meredith President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
585,264
-100.0%
|
-
|
Jul 20
2022
|
Peter F Sr Lyle Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
6,652
-100.0%
|
-
|
Jul 20
2022
|
Peter F Sr Lyle Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,296
-100.0%
|
-
|
Jul 20
2022
|
Robert E Hull EVP - Investments |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
48
-100.0%
|
-
|
Jul 20
2022
|
Robert E Hull EVP - Investments |
SELL
Sale (or disposition) back to the issuer
|
Direct |
185,739
-100.0%
|
-
|
Jul 20
2022
|
Ajay Gupta Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,509
-100.0%
|
-
|
Jul 20
2022
|
J Christopher Douglas Executive VP & CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
229,505
-100.0%
|
-
|
Jul 20
2022
|
Amanda L Callaway SVP & Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
85,184
-100.0%
|
-
|
Jul 20
2022
|
Edward Hall Braman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,285
-100.0%
|
-
|
Jul 20
2022
|
John M Bryant Jr Executive Vice President & GC |
SELL
Sale (or disposition) back to the issuer
|
Direct |
208,573
-100.0%
|
-
|
Jul 20
2022
|
John V Abbott Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,161
-100.0%
|
-
|
Jul 20
2022
|
Nancy H Agee Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
31,789
-100.0%
|
-
|
Jul 20
2022
|
Nancy H Agee Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
3,431
-100.0%
|
-
|
May 13
2022
|
Nancy H Agee Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,355
+9.55%
|
$97,295
$29.8 P/Share
|
May 13
2022
|
Christann M Vasquez Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,355
+10.52%
|
$97,295
$29.8 P/Share
|
May 13
2022
|
John V Abbott Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,355
+20.31%
|
$97,295
$29.8 P/Share
|
May 13
2022
|
James Joseph Iv Kilroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,355
+25.27%
|
$97,295
$29.8 P/Share
|
May 13
2022
|
John Knox Singleton Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,355
+8.07%
|
$97,295
$29.8 P/Share
|
May 13
2022
|
Ajay Gupta Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,355
+34.01%
|
$97,295
$29.8 P/Share
|
May 13
2022
|
Peter F Sr Lyle Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,355
+21.44%
|
$97,295
$29.8 P/Share
|
May 13
2022
|
Edward Hall Braman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,355
+12.14%
|
$97,295
$29.8 P/Share
|
Feb 22
2022
|
Julie F. Wilson EVP - Operations |
BUY
Grant, award, or other acquisition
|
Direct |
10,586
+10.21%
|
$317,580
$30.85 P/Share
|
Feb 22
2022
|
John M Bryant Jr Executive Vice President & GC |
BUY
Grant, award, or other acquisition
|
Direct |
14,294
+6.41%
|
$428,820
$30.85 P/Share
|
Feb 22
2022
|
Todd J Meredith President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,562
+4.81%
|
$886,860
$30.85 P/Share
|
Feb 22
2022
|
J Christopher Douglas Executive VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,089
+6.17%
|
$452,670
$30.85 P/Share
|
Feb 22
2022
|
Amanda L Callaway SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,879
+7.47%
|
$206,370
$30.85 P/Share
|
Feb 22
2022
|
Robert E Hull EVP - Investments |
BUY
Grant, award, or other acquisition
|
Direct |
14,294
+7.15%
|
$428,820
$30.85 P/Share
|
Feb 03
2022
|
Amanda L Callaway SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
249
-0.32%
|
$7,470
$30.7 P/Share
|
Jan 03
2022
|
Julie F. Wilson EVP - Operations |
BUY
Grant, award, or other acquisition
|
Direct |
17,308
+17.34%
|
$536,548
$31.48 P/Share
|
Jan 03
2022
|
Robert E Hull EVP - Investments |
BUY
Grant, award, or other acquisition
|
Direct |
20,920
+10.88%
|
$648,520
$31.48 P/Share
|
Jan 03
2022
|
Amanda L Callaway SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,705
+11.0%
|
$300,855
$31.48 P/Share
|
Jan 03
2022
|
J Christopher Douglas Executive VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
21,420
+9.08%
|
$664,020
$31.48 P/Share
|
Jan 03
2022
|
John M Bryant Jr Executive Vice President & GC |
BUY
Grant, award, or other acquisition
|
Direct |
19,729
+9.22%
|
$611,599
$31.48 P/Share
|
Jan 03
2022
|
Todd J Meredith President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
55,263
+9.05%
|
$1,713,153
$31.48 P/Share
|
Jan 01
2022
|
J Christopher Douglas Executive VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,180
+1.62%
|
$98,580
$31.43 P/Share
|
Dec 31
2021
|
John M Bryant Jr Executive Vice President & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
2,434
-1.38%
|
$75,454
$31.64 P/Share
|
Dec 31
2021
|
Todd J Meredith President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,245
-0.64%
|
$100,595
$31.64 P/Share
|
Dec 15
2021
|
Julie F. Wilson EVP - Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
3,310
-4.83%
|
$102,610
$31.75 P/Share
|
Dec 15
2021
|
Todd J Meredith President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,697
-1.89%
|
$300,607
$31.75 P/Share
|
Dec 15
2021
|
J Christopher Douglas Executive VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,697
-4.86%
|
$300,607
$31.75 P/Share
|
Dec 15
2021
|
John M Bryant Jr Executive Vice President & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
9,697
-5.19%
|
$300,607
$31.75 P/Share
|
Dec 15
2021
|
Robert E Hull EVP - Investments |
SELL
Payment of exercise price or tax liability
|
Direct |
4,762
-3.07%
|
$147,622
$31.75 P/Share
|
Dec 15
2021
|
Amanda L Callaway SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,915
-5.38%
|
$121,365
$31.75 P/Share
|
Sep 23
2021
|
John M Bryant Jr Executive Vice President & GC |
SELL
Open market or private sale
|
Direct |
2,896
-1.53%
|
$89,776
$31.01 P/Share
|
May 11
2021
|
Edward Hall Braman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,154
+13.1%
|
$97,774
$31.7 P/Share
|